CHI3L1 and myeloid sarcoma: All three biomarkers were significantly elevated in MS patients with active lesional activity compared to inactive patients, but with a less strong statistical effect (IL-12p40, CHI3L1, and cNfL unadjusted p = 0.0145, 0.0319, and 0.0335, respectively; Figure 6A).